Newsfeeds - Spark Newswire

2 minute read

Analyzing Apollo Endosurgery’s Short Interest

Today, 1:04 PM

Apollo Endosurgery's (NASDAQ:APEN) short percent of float has fallen 63.08% since its last report. The company recently reported that it has 425 thousand shares sold short, which is 1.2% of all regular shares that are available for trading.

APEN

20 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 4, 2023

By Benzinga Insights

Today, 1:04 PM

Upgrades UBS upgraded the previous rating for Trane Technologies PLC (NYSE:TT) from Neutral to Buy. For the third…

ADSE

1 minute read

Stifel Downgrades Apollo Endosurgery to Hold, Announces $10 Price Target

By Benzinga Newsdesk

Today, 1:04 PM

Stifel analyst Mathew Blackman downgrades Apollo Endosurgery (NASDAQ:APEN) from Buy to Hold and announces $10 price target.

APEN

4 minute read

10 Best Stock Traders In Congress In 2022 (Spoiler: Nancy Pelosi Isn’t No. 1)

By Chris Katje

Today, 1:04 PM

A new report was out about the performance of members of the U.S. Congress who bought and sold stocks and options in 2022. The report broke down unusual trading activity from members of Congress and also showed the members who beat the returns of the S&P 500. Here are the highlights of the report.

AAPL

2 minute read

Apollo Endosurgery Announces American Society for Metabolic and Bariatric Surgery Added Apollo Systems To List Of FDA Approved Bariatric Devices On December 5

By Benzinga Newsdesk

Today, 1:04 PM

Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that the MERIT trial, published in The

APEN